pafuramidine   Click here for help

GtoPdb Ligand ID: 10842

Synonyms: DB-289 | DB289
Compound class: Synthetic organic
Comment: Pafuramidine (DB-289) is a prodrug which generates the active moiety DB-75 which exhibits antiprotozoal and antifungal activities [1]. It is a pentamidine-related dicationic molecule. Mechanistically, the drug binds to the minor groove of DNA. It has activity against parasites and also Mycobacterium tuberculosis.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 108.36
Molecular weight 364.15
XLogP 4.7
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CO/N=C(/c1ccc(cc1)c1ccc(o1)c1ccc(cc1)/C(=N/OC)/N)\N
Isomeric SMILES CO/N=C(/c1ccc(cc1)c1ccc(o1)c1ccc(cc1)/C(=N/OC)/N)\N
InChI InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)
InChI Key UKOQVLAXCBRRGH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Pafuramidine was advanced to clinical trials but not for bacterial infections. Phase 1 trials demonstrated safety in humans.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00803933 Trial of DB289 for the Treatment of Stage I African Trypanosomiasis Phase 2 Interventional Immtech Pharmaceuticals, Inc
NCT00302341 DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Phase 3 Interventional Immtech Pharmaceuticals, Inc This trial was put on hold by the FDA in 2007, due to safety concerns, and was subsequently terminated.
NCT00408369 Prophylactic Antimalarial Activity of DB289 in Volunteers Phase 1/Phase 2 Interventional Immtech Pharmaceuticals, Inc 2